Skip to content

High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients

Impact of High-Flow Tracheal Therapy on the Rheological Properties of Tracheobronchial Secretions in Tracheostomized Patients: A Randomized Crossover Study.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06897319
Acronym
TRACH2O
Enrollment
15
Registered
2025-03-26
Start date
2026-06-20
Completion date
2027-08-01
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheostomized Patients

Brief summary

This monocentric, randomized crossover study aims to assess the impact of high-flow tracheal therapy (HFT) on the rheological properties of tracheobronchopulmonary secretions in tracheostomized patients. The primary objective is to compare the viscoelastic characteristics of secretions collected with and without HFT. Secondary objectives include evaluating the effects of HFT on dyspnea, patient comfort, and secretion appearance. The study will take place at Cliniques Universitaires Saint-Luc, with adult tracheostomized patients undergoing standard care.

Interventions

DEVICEHigh-Flow Tracheal Therapy

Device: Airvo 2 (Fisher \& Paykel Healthcare) Settings: Flow rate start at 40L/min and will be adapted according to tolerance; temperature aimed at 37°C or 34°C according to tolerance, FiO₂ set (if needed) according to SpO2 target values.

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (≥18 years old) * Tracheostomized patients * Patients requiring routine tracheal suctioning and already using HFT overnight

Exclusion criteria

* Insufficient secretions for analysis * Cognitive impairment or confusion

Design outcomes

Primary

MeasureTime frameDescription
Critical stress (σc)Measured three times: at baseline, after one hour, after 4 hoursThe rheological properties measured using Rheomuco (Rheonova) will be sampled during a suctioning procedure. The critical stress σc = G\*(γc).γc, where G\*(γc) is the viscoelastic modulus measured at the critical strain, is the measured stress at which this transition occurs. See the description of the other rheological outcomes in the secondary outcomes.

Secondary

MeasureTime frameDescription
Dyspnea (modified Borg scale)Measured two times: at baseline and after 4 hoursThe modified Borg Scale (from 0 : no dyspnea; to 10 : maximal dyspnea) will be used
Patient Comfort (Visual Analog Scale - VAS)Measured two times: at baseline and after 4 hoursThe VAS (from 0 : extremely comfortable; to 10 : extremely uncomfortable) will be used
Secretion Appearance (Murray Scale)Measured two times: at baseline and after 4 hoursThe Murray scale define the following secretion appearance: * Mucoid * Mucopurulent * Purulent
Viscoelastic modulus (G*)Measured three times: at baseline, after one hour, after 4 hoursThe rheological properties measured using Rheomuco (Rheonova) will be sampled during a suctioning procedure. The ratio of the stress to the strain, the viscoelastic modulus G\* , describes the molecular network force in response to shear. In viscoelastic materials, the viscous dissipation shifts in time the stress response to the imposed strain, which is quantified by the damping ratio tan δ. Both G\* and tan δ provide the viscous and elastic moduli, G' and G''. See the description of the other rheological outcomes in the secondary outcomes.
Damping ratio (tan δ)Measured three times: at baseline, after one hour, after 4 hoursThe rheological properties measured using Rheomuco (Rheonova) will be sampled during a suctioning procedure. At given deformation, a damping ratio above 1 would describe a predominantly viscous material (G'' \> G'), i.e. that behaves like a liquid, whereas a damping ratio below 1 denotes a predominantly elastic material (G' \> G''), that exhibits a solid-like behavior.
Critical strain (γc)Measured three times: at baseline, after one hour, after 4 hoursThe rheological properties measured using Rheomuco (Rheonova) will be sampled during a suctioning procedure. The viscoelastic characteristics are measured at increasing strains, ranging from about 1 % to about 10000 %. At a critical strain value, γc, typically around or above 1000 % for sputa, the G' and G'' curves cross over (the damping ratio overcomes 1). Beyond this critical point, the sample becomes predominantly viscous over elastic (fluid-like) under strain and starts to flow. See the description of the other rheological outcomes in the secondary outcomes.

Countries

Belgium

Contacts

CONTACTWilliam Poncin, PhD
william.poncin@uclouvain.be+3227641111
PRINCIPAL_INVESTIGATORWilliam Poncin, PhD

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026